These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12270442)

  • 1. Pharmacodynamics of the immunosuppressive effects of the combination of tacrolimus with mycophenolate mofetil.
    Barten MJ; Rahmel A; Richter M; Tarnok A; Bartsch P; Boeger M; Gehlhaar P; Dhein S; Mohr FW; Gummert JF
    Transplant Proc; 2002 Sep; 34(6):2372-3. PubMed ID: 12270442
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of FK 506 and mycophenolic acid after the administration of a FK 506-based regimen in combination with mycophenolate mofetil in kidney transplantation.
    Undre NA; van Hooff J; Christiaans M; Vanrenterghem Y; Donck J; Heeman U; Kohnle M; Zanker B; Land W; Morales JM; Andrés A; Schäfer A; Stevenson P
    Transplant Proc; 1998 Jun; 30(4):1299-302. PubMed ID: 9636527
    [No Abstract]   [Full Text] [Related]  

  • 3. New mechanisms of action of mycophenolate mofetil in transplant recipients by assessment of its pharmacodynamics.
    Barten MJ; van Gelder T; Gummert JF; Shorthouse R; Boeke K; Billingham ME; Morris RE
    Transplant Proc; 2001 May; 33(3):2254-5. PubMed ID: 11377519
    [No Abstract]   [Full Text] [Related]  

  • 4. Tacrolimus and mycophenolate mofetil in pig small bowel transplantation: different protocols and their outcome.
    Spada M; Alessiani M; Ferrari P; Iacona I; Abbiati F; Viezzoli A; Regazzi MB; Bellinzona G; Dionigi P; Zonta A
    Transplant Proc; 1997 May; 29(3):1819-20. PubMed ID: 9142286
    [No Abstract]   [Full Text] [Related]  

  • 5. Mycophenolate mofetil pharmacodynamics and pharmacokinetics correlate with rejection score in a BN-to-LEW heterotopic heart transplant model.
    Klupp J; van Gelder T; Dambrin C; Regieli J; Boeke K; Billingham ME; Morris RE
    Transplant Proc; 2001 May; 33(3):2170-1. PubMed ID: 11377490
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics of FK506 and mycophenolic acid in experimental and clinical intestinal transplantation.
    Regazzi MB; Alessiani M; Reggiani P; Gatti S; Spada M; Iacona I; Rossi G; Tzakis A
    Transplant Proc; 1997 May; 29(3):1857-60. PubMed ID: 9142302
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of mycophenolic acid after enteric-coated mycophenolate versus mycophenolate mofetil in patients with progressive IgA nephritis.
    Czock D; Rasche FM; Carius A; Glander P; Budde K; Bauer S; Keller F; von Müller L
    J Clin Pharmacol; 2007 Jul; 47(7):850-9. PubMed ID: 17526858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunosuppressive drug monitoring of cyclosporine, tacrolimus, and mycophenolate mofetil in renal transplantation].
    Uchida K
    Nihon Jinzo Gakkai Shi; 2005; 47(4):423-9. PubMed ID: 15971884
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of oral mycophenolate mofetil in dog: bioavailability studies and the impact of antibiotic therapy.
    Lupu M; McCune JS; Kuhr CS; Gooley T; Storb R
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1352-4. PubMed ID: 17162219
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients.
    Nashan B; Saliba F; Durand F; Barcéna R; Herrero JI; Mentha G; Neuhaus P; Bowles M; Patch D; Bernardos A; Klempnauer J; Bouw R; Ives J; Mamelok R; McKay D; Truman M; Marotta P
    Liver Transpl; 2009 Feb; 15(2):136-47. PubMed ID: 19177449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus and mycophenolate mofetil provide effective immunosuppression in rat laryngeal transplantation.
    Nelson M; Fritz M; Dan O; Worley S; Strome M
    Laryngoscope; 2003 Aug; 113(8):1308-13. PubMed ID: 12897551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroregeneration in composite tissue allografts: effect of low-dose FK506 and mycophenolate mofetil immunotherapy.
    Cottrell BL; Perez-Abadia G; Onifer SM; Magnuson DS; Burke DA; Grossi FV; Francois CG; Barker JH; Maldonado C
    Plast Reconstr Surg; 2006 Sep; 118(3):615-23; discussion 624-5. PubMed ID: 16932168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus pharmacokinetic drug interactions: effect of prednisone, mycophenolic acid or sirolimus.
    Park SI; Felipe CR; Pinheiro-Machado PG; Garcia R; Fernandes FB; Casarini DE; Tedesco-Silva H; Medina-Pestana JO
    Fundam Clin Pharmacol; 2009 Feb; 23(1):137-45. PubMed ID: 19267777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes.
    Budde K; Glander P; Krämer BK; Fischer W; Hoffmann U; Bauer S; Grohmann J; Neumayer HH; Arns W
    Transplantation; 2007 Feb; 83(4):417-24. PubMed ID: 17318074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug interaction between mycophenolate mofetil and tacrolimus detectable within therapeutic mycophenolic acid monitoring in renal transplant patients.
    van Gelder T; Smak Gregoor PJ; Weimar W
    Ther Drug Monit; 2000 Oct; 22(5):639. PubMed ID: 11034275
    [No Abstract]   [Full Text] [Related]  

  • 16. The pharmacokinetics of a single oral dose of mycophenolate mofetil in patients with varying degrees of renal function.
    Johnson HJ; Swan SK; Heim-Duthoy KL; Nicholls AJ; Tsina I; Tarnowski T
    Clin Pharmacol Ther; 1998 May; 63(5):512-8. PubMed ID: 9630824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring.
    Ciancio G; Burke GW; Gaynor JJ; Carreno MR; Cirocco RE; Mathew JM; Mattiazzi A; Cordovilla T; Roth D; Kupin W; Rosen A; Esquenazi V; Tzakis AG; Miller J
    Transplantation; 2005 Aug; 80(4):457-65. PubMed ID: 16123718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus dose requirement in renal transplant recipients is significantly higher when used in combination with corticosteroids.
    Hesselink DA; Ngyuen H; Wabbijn M; Gregoor PJ; Steyerberg EW; van Riemsdijk IC; Weimar W; van Gelder T
    Br J Clin Pharmacol; 2003 Sep; 56(3):327-30. PubMed ID: 12919182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mycophenolate mofetil in renal transplantation].
    Uchida K
    Nihon Rinsho; 2005 May; 63 Suppl 5():684-91. PubMed ID: 15954430
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel anti-Pneumocystis carinii effects of the immunosuppressant mycophenolate mofetil in contrast to provocative effects of tacrolimus, sirolimus, and dexamethasone.
    Oz HS; Hughes WT
    J Infect Dis; 1997 Apr; 175(4):901-4. PubMed ID: 9086147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.